These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23362583)

  • 1. The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
    Fox R
    Can J Neurosci Nurs; 2012; 34(3):7-11. PubMed ID: 23362583
    [No Abstract]   [Full Text] [Related]  

  • 2. Trial watch: Phase III success for Biogen's oral multiple sclerosis therapy.
    Nat Rev Drug Discov; 2011 Jun; 10(6):404. PubMed ID: 21629281
    [No Abstract]   [Full Text] [Related]  

  • 3. Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis.
    Venci JV; Gandhi MA
    Ann Pharmacother; 2013 Dec; 47(12):1697-702. PubMed ID: 24259625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing and overcoming potential barriers to oral medications for MS.
    Moses H
    J Clin Psychiatry; 2014 Oct; 75(10):e28. PubMed ID: 25373133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral therapy approved for multiple sclerosis.
    Traynor K
    Am J Health Syst Pharm; 2013 May; 70(9):744. PubMed ID: 23592350
    [No Abstract]   [Full Text] [Related]  

  • 6. Dimethyl fumarate (Tecfidera) for multiple sclerosis.
    Med Lett Drugs Ther; 2013 Jun; 55(1418):45-7. PubMed ID: 24662841
    [No Abstract]   [Full Text] [Related]  

  • 7. Dimethyl fumarate for multiple sclerosis.
    Papadopoulou A; D'Souza M; Kappos L; Yaldizli O
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1603-12. PubMed ID: 21067468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral fumarate for relapsing-remitting multiple sclerosis.
    Sorensen PS; Sellebjerg F
    Lancet; 2008 Oct; 372(9648):1447-8. PubMed ID: 18970966
    [No Abstract]   [Full Text] [Related]  

  • 9. New oral drugs for multiple sclerosis.
    Gasperini C; Ruggieri S
    Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.
    Stangel M; Linker RA
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):355-62. PubMed ID: 23927662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic fasciitis-like disorder developing in the setting of multiple sclerosis therapy.
    Sheu J; Kattapuram SV; Stankiewicz JM; Merola JF
    J Drugs Dermatol; 2014 Sep; 13(9):1144-7. PubMed ID: 25226017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
    Linker RA; Gold R
    Curr Neurol Neurosci Rep; 2013 Nov; 13(11):394. PubMed ID: 24061646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML in a patient with lymphocytopenia treated with dimethyl fumarate.
    Rosenkranz T; Novas M; Terborg C
    N Engl J Med; 2015 Apr; 372(15):1476-8. PubMed ID: 25853765
    [No Abstract]   [Full Text] [Related]  

  • 14. Lorcaserin, dimethyl fumarate, and bedaquiline fumarate.
    Hussar DA; Polyak G
    J Am Pharm Assoc (2003); 2013; 53(3):328-30, 332, 334. PubMed ID: 23699683
    [No Abstract]   [Full Text] [Related]  

  • 15. BG-12 in multiple sclerosis.
    Phillips JT; Fox RJ
    Semin Neurol; 2013 Feb; 33(1):56-65. PubMed ID: 23709213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BG 12: BG 00012, BG 12/Oral Fumarate, FAG-201, second-generation fumarate derivative--Fumapharm/Biogen Idec.
    Drugs R D; 2005; 6(4):229-30. PubMed ID: 15991882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diroximel fumarate to treat multiple sclerosis.
    Wang Y; Bhargava P
    Drugs Today (Barc); 2020 Jul; 56(7):431-437. PubMed ID: 32648853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fingolimod (gilenya) for multiple sclerosis.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):98-9. PubMed ID: 21344782
    [No Abstract]   [Full Text] [Related]  

  • 19. Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
    Ratchford EV; Baldanza JT; Pardo CA
    J Neurol; 2014 Apr; 261(4):831-2. PubMed ID: 24603974
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
    Methner A; Zipp F
    Nat Rev Neurol; 2013 Feb; 9(2):72-3. PubMed ID: 23338282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.